Click for best price
AntiInfective Vaccines Market Size, Share 2022
Market Analysis and Insights: Global AntiInfective Vaccines Market
The global AntiInfective Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global AntiInfective Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global AntiInfective Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global AntiInfective Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global AntiInfective Vaccines market.
Global AntiInfective Vaccines Scope and Market Size
Anti-Infective Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anti-Infective Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Anti-Infective Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines
Segment by Application
Bacterial Diseases
Viral Diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes AntiInfective Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of AntiInfective Vaccines, with price, sales, revenue, and global market share of AntiInfective Vaccines from 2019 to 2022.
Chapter 3, the AntiInfective Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AntiInfective Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the AntiInfective Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of AntiInfective Vaccines.
Chapter 13, 14, and 15, to describe AntiInfective Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 AntiInfective Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Anti-Infective Vaccines Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Anti-Infective Vaccines Product Introduction
1.2 Global Anti-Infective Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anti-Infective Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anti-Infective Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Anti-Infective Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anti-Infective Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anti-Infective Vaccines Sales in Volume for the Year 2017-2028
1.4 Anti-Infective Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anti-Infective Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anti-Infective Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anti-Infective Vaccines Market Dynamics
1.5.1 Anti-Infective Vaccines Industry Trends
1.5.2 Anti-Infective Vaccines Market Drivers
1.5.3 Anti-Infective Vaccines Market Challenges
1.5.4 Anti-Infective Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Anti-Infective Vaccines Market Segment by Type
2.1.1 Inactivated Vaccines
2.1.2 Conjugate Vaccines
2.1.3 Live/attenuated Vaccines
2.2 Global Anti-Infective Vaccines Market Size by Type
2.2.1 Global Anti-Infective Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anti-Infective Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anti-Infective Vaccines Market Size by Type
2.3.1 United States Anti-Infective Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anti-Infective Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anti-Infective Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Anti-Infective Vaccines Market Segment by Application
3.1.1 Bacterial Diseases
3.1.2 Viral Diseases
3.2 Global Anti-Infective Vaccines Market Size by Application
3.2.1 Global Anti-Infective Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anti-Infective Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anti-Infective Vaccines Market Size by Application
3.3.1 United States Anti-Infective Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anti-Infective Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anti-Infective Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Anti-Infective Vaccines Competitor Landscape by Company
4.1 Global Anti-Infective Vaccines Market Size by Company
4.1.1 Top Global Anti-Infective Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anti-Infective Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Anti-Infective Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Anti-Infective Vaccines Price by Manufacturer (2017-2022)
4.2 Global Anti-Infective Vaccines Concentration Ratio (CR)
4.2.1 Anti-Infective Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Infective Vaccines in 2021
4.2.3 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anti-Infective Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Anti-Infective Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anti-Infective Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anti-Infective Vaccines Market Size by Company
4.5.1 Top Anti-Infective Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anti-Infective Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anti-Infective Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Anti-Infective Vaccines Market Size by Region
5.1 Global Anti-Infective Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anti-Infective Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Anti-Infective Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Anti-Infective Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anti-Infective Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Anti-Infective Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Anti-Infective Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anti-Infective Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Emergent BioDefense Operations Lansing Inc.
7.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
7.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
7.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
7.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporation Information
7.2.2 Sanofi Pasteur Description and Business Overview
7.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
7.2.5 Sanofi Pasteur Recent Development
7.3 Merck & Co.
7.3.1 Merck & Co. Corporation Information
7.3.2 Merck & Co. Description and Business Overview
7.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
7.3.5 Merck & Co. Recent Development
7.4 MedImmune LLC
7.4.1 MedImmune LLC Corporation Information
7.4.2 MedImmune LLC Description and Business Overview
7.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
7.4.5 MedImmune LLC Recent Development
7.5 Novartis Vaccines
7.5.1 Novartis Vaccines Corporation Information
7.5.2 Novartis Vaccines Description and Business Overview
7.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
7.5.5 Novartis Vaccines Recent Development
7.6 Diagnostics Ltd.
7.6.1 Diagnostics Ltd. Corporation Information
7.6.2 Diagnostics Ltd. Description and Business Overview
7.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
7.6.5 Diagnostics Ltd. Recent Development
7.7 Intercell Biomedical
7.7.1 Intercell Biomedical Corporation Information
7.7.2 Intercell Biomedical Description and Business Overview
7.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
7.7.5 Intercell Biomedical Recent Development
7.8 MassBiologics
7.8.1 MassBiologics Corporation Information
7.8.2 MassBiologics Description and Business Overview
7.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 MassBiologics Anti-Infective Vaccines Products Offered
7.8.5 MassBiologics Recent Development
7.9 Barr Labs, Inc.
7.9.1 Barr Labs, Inc. Corporation Information
7.9.2 Barr Labs, Inc. Description and Business Overview
7.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
7.9.5 Barr Labs, Inc. Recent Development
7.10 Organon Teknika Co.
7.10.1 Organon Teknika Co. Corporation Information
7.10.2 Organon Teknika Co. Description and Business Overview
7.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
7.10.5 Organon Teknika Co. Recent Development
7.11 GlaxoSmithKline Biologicals
7.11.1 GlaxoSmithKline Biologicals Corporation Information
7.11.2 GlaxoSmithKline Biologicals Description and Business Overview
7.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Products Offered
7.11.5 GlaxoSmithKline Biologicals Recent Development
7.12 CSL Ltd.
7.12.1 CSL Ltd. Corporation Information
7.12.2 CSL Ltd. Description and Business Overview
7.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 CSL Ltd. Products Offered
7.12.5 CSL Ltd. Recent Development
7.13 ID Biomedical Co.
7.13.1 ID Biomedical Co. Corporation Information
7.13.2 ID Biomedical Co. Description and Business Overview
7.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 ID Biomedical Co. Products Offered
7.13.5 ID Biomedical Co. Recent Development
7.14 Protein Sciences Co.
7.14.1 Protein Sciences Co. Corporation Information
7.14.2 Protein Sciences Co. Description and Business Overview
7.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Protein Sciences Co. Products Offered
7.14.5 Protein Sciences Co. Recent Development
7.15 Wyeth Pharmaceuticals, Inc.
7.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
7.15.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
7.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Wyeth Pharmaceuticals, Inc. Products Offered
7.15.5 Wyeth Pharmaceuticals, Inc. Recent Development
7.16 Berna Biotech
7.16.1 Berna Biotech Corporation Information
7.16.2 Berna Biotech Description and Business Overview
7.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Berna Biotech Products Offered
7.16.5 Berna Biotech Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Anti-Infective Vaccines Industry Chain Analysis
8.2 Anti-Infective Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anti-Infective Vaccines Distributors
8.3 Anti-Infective Vaccines Production Mode & Process
8.4 Anti-Infective Vaccines Sales and Marketing
8.4.1 Anti-Infective Vaccines Sales Channels
8.4.2 Anti-Infective Vaccines Distributors
8.5 Anti-Infective Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-Infective Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Anti-Infective Vaccines Market Trends
Table 3. Anti-Infective Vaccines Market Drivers
Table 4. Anti-Infective Vaccines Market Challenges
Table 5. Anti-Infective Vaccines Market Restraints
Table 6. Global Anti-Infective Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Anti-Infective Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Anti-Infective Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Anti-Infective Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Anti-Infective Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Anti-Infective Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Anti-Infective Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Anti-Infective Vaccines Sales by Manufacturer, (Units), 2017-2022
Table 14. Global Anti-Infective Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Anti-Infective Vaccines Price by Manufacturer (2017-2022) & (US$/Unit)
Table 16. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2021)
Table 18. Top Players of Anti-Infective Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Anti-Infective Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Anti-Infective Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Anti-Infective Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Anti-Infective Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Anti-Infective Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Anti-Infective Vaccines Sales by Players, (Units), 2020, 2021 & 2022
Table 26. United States Anti-Infective Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Anti-Infective Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Anti-Infective Vaccines Sales in Volume by Region (2017-2022) & (Units)
Table 29. Global Anti-Infective Vaccines Sales in Volume Forecast by Region (2023-2028) & (Units)
Table 30. Global Anti-Infective Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Anti-Infective Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Anti-Infective Vaccines Sales in Volume by Country (2017-2028) & (Units)
Table 33. North America Anti-Infective Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Anti-Infective Vaccines Sales in Volume by Region (2017-2028) & (Units)
Table 35. Asia Pacific Anti-Infective Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Anti-Infective Vaccines Sales in Volume by Country (2017-2028) & (Units)
Table 37. Europe Anti-Infective Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Anti-Infective Vaccines Sales in Volume by Country (2017-2028) & (Units)
Table 39. Latin Americaa Anti-Infective Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Anti-Infective Vaccines Sales in Volume by Country (2017-2028) & (Units)
Table 41. Middle East and Africa Anti-Infective Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 43. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 44. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 45. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 46. Emergent BioDefense Operations Lansing Inc. Recent Development
Table 47. Sanofi Pasteur Corporation Information
Table 48. Sanofi Pasteur Description and Business Overview
Table 49. Sanofi Pasteur Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 50. Sanofi Pasteur Product
Table 51. Sanofi Pasteur Recent Development
Table 52. Merck & Co. Corporation Information
Table 53. Merck & Co. Description and Business Overview
Table 54. Merck & Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 55. Merck & Co. Product
Table 56. Merck & Co. Recent Development
Table 57. MedImmune LLC Corporation Information
Table 58. MedImmune LLC Description and Business Overview
Table 59. MedImmune LLC Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 60. MedImmune LLC Product
Table 61. MedImmune LLC Recent Development
Table 62. Novartis Vaccines Corporation Information
Table 63. Novartis Vaccines Description and Business Overview
Table 64. Novartis Vaccines Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 65. Novartis Vaccines Product
Table 66. Novartis Vaccines Recent Development
Table 67. Diagnostics Ltd. Corporation Information
Table 68. Diagnostics Ltd. Description and Business Overview
Table 69. Diagnostics Ltd. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 70. Diagnostics Ltd. Product
Table 71. Diagnostics Ltd. Recent Development
Table 72. Intercell Biomedical Corporation Information
Table 73. Intercell Biomedical Description and Business Overview
Table 74. Intercell Biomedical Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 75. Intercell Biomedical Product
Table 76. Intercell Biomedical Recent Development
Table 77. MassBiologics Corporation Information
Table 78. MassBiologics Description and Business Overview
Table 79. MassBiologics Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 80. MassBiologics Product
Table 81. MassBiologics Recent Development
Table 82. Barr Labs, Inc. Corporation Information
Table 83. Barr Labs, Inc. Description and Business Overview
Table 84. Barr Labs, Inc. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 85. Barr Labs, Inc. Product
Table 86. Barr Labs, Inc. Recent Development
Table 87. Organon Teknika Co. Corporation Information
Table 88. Organon Teknika Co. Description and Business Overview
Table 89. Organon Teknika Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 90. Organon Teknika Co. Product
Table 91. Organon Teknika Co. Recent Development
Table 92. GlaxoSmithKline Biologicals Corporation Information
Table 93. GlaxoSmithKline Biologicals Description and Business Overview
Table 94. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 95. GlaxoSmithKline Biologicals Product
Table 96. GlaxoSmithKline Biologicals Recent Development
Table 97. CSL Ltd. Corporation Information
Table 98. CSL Ltd. Description and Business Overview
Table 99. CSL Ltd. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 100. CSL Ltd. Product
Table 101. CSL Ltd. Recent Development
Table 102. ID Biomedical Co. Corporation Information
Table 103. ID Biomedical Co. Description and Business Overview
Table 104. ID Biomedical Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 105. ID Biomedical Co. Product
Table 106. ID Biomedical Co. Recent Development
Table 107. Protein Sciences Co. Corporation Information
Table 108. Protein Sciences Co. Description and Business Overview
Table 109. Protein Sciences Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Protein Sciences Co. Product
Table 111. Protein Sciences Co. Recent Development
Table 112. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 113. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 114. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Wyeth Pharmaceuticals, Inc. Product
Table 116. Wyeth Pharmaceuticals, Inc. Recent Development
Table 117. Berna Biotech Corporation Information
Table 118. Berna Biotech Description and Business Overview
Table 119. Berna Biotech Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Berna Biotech Product
Table 121. Berna Biotech Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Anti-Infective Vaccines Customers List
Table 125. Anti-Infective Vaccines Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Vaccines Product Picture
Figure 2. Global Anti-Infective Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Anti-Infective Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Anti-Infective Vaccines Sales 2017-2028 (Units)
Figure 5. United States Anti-Infective Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Anti-Infective Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Anti-Infective Vaccines Sales 2017-2028 (Units)
Figure 8. United States Anti-Infective Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Anti-Infective Vaccines Market Share in Global, in Volume (Units) 2017-2028
Figure 10. Anti-Infective Vaccines Report Years Considered
Figure 11. Product Picture of Inactivated Vaccines
Figure 12. Product Picture of Conjugate Vaccines
Figure 13. Product Picture of Live/attenuated Vaccines
Figure 14. Global Anti-Infective Vaccines Market Share by Type in 2022 & 2028
Figure 15. Global Anti-Infective Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Anti-Infective Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Anti-Infective Vaccines Sales by Type (2017-2028) & (Units)
Figure 18. Global Anti-Infective Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Anti-Infective Vaccines Price by Type (2017-2028) & (US$/Unit)
Figure 20. United States Anti-Infective Vaccines Market Share by Type in 2022 & 2028
Figure 21. United States Anti-Infective Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Anti-Infective Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Anti-Infective Vaccines Sales by Type (2017-2028) & (Units)
Figure 24. United States Anti-Infective Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Anti-Infective Vaccines Price by Type (2017-2028) & (US$/Unit)
Figure 26. Product Picture of Bacterial Diseases
Figure 27. Product Picture of Viral Diseases
Figure 28. Global Anti-Infective Vaccines Market Share by Application in 2022 & 2028
Figure 29. Global Anti-Infective Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Anti-Infective Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Anti-Infective Vaccines Sales by Application (2017-2028) & (Units)
Figure 32. Global Anti-Infective Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Anti-Infective Vaccines Price by Application (2017-2028) & (US$/Unit)
Figure 34. United States Anti-Infective Vaccines Market Share by Application in 2022 & 2028
Figure 35. United States Anti-Infective Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Anti-Infective Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Anti-Infective Vaccines Sales by Application (2017-2028) & (Units)
Figure 38. United States Anti-Infective Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Anti-Infective Vaccines Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Anti-Infective Vaccines Sales in Volume Growth Rate 2017-2028 (Units)
Figure 41. North America Anti-Infective Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Anti-Infective Vaccines Sales in Volume Growth Rate 2017-2028 (Units)
Figure 45. Europe Anti-Infective Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Anti-Infective Vaccines Sales in Volume Growth Rate 2017-2028 (Units)
Figure 52. Asia-Pacific Anti-Infective Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Anti-Infective Vaccines Sales in Volume Growth Rate 2017-2028 (Units)
Figure 64. Latin America Anti-Infective Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Anti-Infective Vaccines Sales in Volume Growth Rate 2017-2028 (Units)
Figure 69. Middle East & Africa Anti-Infective Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Anti-Infective Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Anti-Infective Vaccines Value Chain
Figure 74. Anti-Infective Vaccines Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
